Michael L. Meyers, SVP, Chief Medical Officer at Syndax Pharmaceuticals Inc (SNDX), bought 1,104 shares at $4.93 ($5K) on 2019-03-21, disclosed to the SEC on 2019-03-22.
Open-market purchase of $5k SNDX by SVP, Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.87 | 104 | $506 | 9.3% |
| 2 | $4.93 | 1,000 | $5K | 90.7% |
| Total | $4.92 avg | 1,104 | $5K | 100% |
| Filing → |
| SNDX | BUY | 2018-11-07 | $958 | — | Filing → |